Speaker illustration

Professor Bernard David Prendergast

St Thomas' Hospital, London (United Kingdom of Great Britain & Northern Ireland)

Member of:

EAPCI

Professor Prendergast is Chair of Cardiology at The Cleveland Clinic London and a Consultant Cardiologist at St Thomas’ Hospital. Before recruitment to London, he trained in Cardiology in Cardiff, Paris and Edinburgh and undertook Consultant posts at Wythenshawe Hospital, Manchester (2001-2007) and the John Radcliffe Hospital, Oxford (2007-2015). Professor Prendergast is a national and international key opinion leader and in frequent demand as a lecturer and speaker. He has been Honorary Secretary of the British Cardiovascular and Cardiovascular Intervention Societies, and Chairman of the European Society of Cardiology Working Group on Valvular Heart Disease. Research interests, which are delivered via collaborative links between London and Oxford, focus on the epidemiology and treatment of valvular heart disease and he is Course Director of PCR London Valves, the world’s largest specialist meeting in valve intervention.

The Future of TAVI: How are the new 2021 ESC/EACTS VHD guidelines changing management and treatment of patients with aortic stenosis

Event: ESC Congress 2021 - The Digital Experience

Topic: Aortic Valve Stenosis

Session type: Satellite Symposium

Thumbnail

Dealing with transcatheter aortic valve implantation (TAVI) challenges

Event: ESC Congress 2021 - The Digital Experience

Topic: Interventional Cardiology

Session type: Symposium

Thumbnail

TAVI - Transcatheter Aortic Valve Implantation

Event: ESC CONGRESS 2019

Topic: Aortic Valve Intervention

Session type: Live in the Box

Thumbnail

Late Breaking TAVI Registries

Event: ESC Congress 2018

Topic: Aortic Valve Intervention

Session type: Late-Breaking Science

Thumbnail

Treating valves correctly

Event: ESC CONGRESS 2017

Topic: Aortic valve surgery

Session type: Guidelines in Practice

Thumbnail

Image Interpretation with the Masters - Thrombosis of bioprosthetic heart valves

Event: ESC CONGRESS 2017

Topic: Valvular heart disease, other

Session type: Special Session

Thumbnail

How the new European valvular heart disease guidelines could change the treatment of AS patients?

Event: ESC CONGRESS 2017

Topic: Aortic valve disease

Session type: Satellite Symposium

Thumbnail

This is TAVI today - Treatment of aortic stenosis in 2016

Event: ESC CONGRESS 2016

Topic: Aortic valve disease

Session type: Satellite Symposium

Thumbnail

This platform is supported by

logo Novo Nordisk